3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1
2
Phase 2/3
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
21
Breast
12
Gynecologic
11
Genitourinary
4
Head & Neck
3
CNS
3
Other solid neoplasm
2
Lymphoid
2
Tumor-Agnostic
1
Sarcoma
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Classical hematology
1
Conditions
Primary Malignant Neoplasm of Ovary
1
Interventions
Decitabine
4
Busulfan
3
Cyclophosphamide
2
venetoclax
1
fludarabine
1
Paclitaxel
1
Influenza Vaccines
1
Celecoxib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Carboplatin
×
Other neoplasm
×
Clear all
NCT02159820
2014-06-10
DAC and CT
Chinese PLA General Hospital
Phase 2/3
Unknown
500 enrolled